Report Store Get Proposal

Home Blog Tag Osivax

Osivax

Pharma Business news

Jul 11, 2019

Osivax raises USD 9M; Smyraf launched; Revolution secures USD 100M

Osivax raises USD 9 M to boost its universal flu vaccine approach France based biotech startup company Osivax, has secured USD 9 million in Series A financing. A Belgian-based firm Noshaq along with Anaxago, an innovative investment platform led the financing. The proceeds will be used to further advance the cl...

Read More...

A New Era for Multiple Myeloma Treatment: Bispecific Antibodies Enter the Fray

Articles

Jun 10, 2025

ADCs in Lung Cancer Treatment: ENHERTU’s Rise, HER3 & TROP-2 Challenges, and What’s Next in the Pipeline

Articles

May 09, 2025

LEQEMBI: A New Hope for Alzheimer’s Disease Patients

Articles

Feb 12, 2025

Unleashing the Potential: CD38 Directed Therapies Revolutionize Multiple Myeloma Treatment

Articles

Sep 24, 2024

Toll-like Receptors Agonist

TLR 7 and 8 Agonist

Gene Therapies Whitepaper

Toll-like Receptors Agonist

TLR 7 and 8 Agonist

Gene Therapies Whitepaper

Newsletter/Whitepaper